Tower House Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-42,679
| Closed | -$31.8M | – | 4 |
|
|
2021
Q3 | $31.8M | Hold |
42,679
| – | – | 18.06% | 4 |
|
|
2021
Q2 | $27.5M | Sell |
42,679
-8,344
| -16% | -$5.38M | 14.32% | 4 |
|
|
2021
Q1 | $29.1M | Sell |
51,023
-23,977
| -32% | -$13.7M | 14.19% | 4 |
|
|
2020
Q4 | $43.7M | Sell |
75,000
-15,000
| -17% | -$8.74M | 21.32% | 4 |
|
|
2020
Q3 | $46.4M | Buy |
90,000
+5,000
| +6% | +$2.58M | 24.85% | 3 |
|
|
2020
Q2 | $38.4M | Sell |
85,000
-50,000
| -37% | -$22.6M | 18.56% | 3 |
|
|
2020
Q1 | $47.3M | Sell |
135,000
-28,379
| -17% | -$9.95M | 34.87% | 1 |
|
|
2019
Q4 | $60.5M | Sell |
163,379
-26,621
| -14% | -$9.85M | 43.05% | 1 |
|
|
2019
Q3 | $63.2M | Sell |
190,000
-10,000
| -5% | -$3.33M | 52.68% | 1 |
|
|
2019
Q2 | $62.5M | Buy |
200,000
+11,795
| +6% | +$3.69M | 67.3% | 1 |
|
|
2019
Q1 | $57.5M | Sell |
188,205
-36,795
| -16% | -$11.2M | 63.89% | 1 |
|
|
2018
Q4 | $52.2M | Buy |
+225,000
| New | +$52.2M | 100% | 1 |
|